4DS Memory Limited is set to acquire Australian Edge-AI software firm Jenesys, raising $5 million to integrate its autonomous systems capabilities with 4DS’s PCMO ReRAM technology, targeting computing-in-memory and neuromorphic markets.
- 4DS to acquire Jenesys and integrate Edge-AI with ReRAM
- Capital raising of $5 million via rights issue and placement
- Jaspal Sarai to join 4DS board as MD and CEO
- Focus on computing-in-memory and neuromorphic computing
- Transaction expected to complete by October 2026
Strategic Acquisition to Broaden 4DS’s Market Reach
4DS Memory Limited (ASX:4DS) has struck a binding deal to acquire Jenesys Pty Ltd, an Australian software developer specialising in Edge-AI and autonomous systems. The move aims to marry Jenesys’s intelligent coordination software with 4DS’s proprietary PCMO ReRAM hardware, creating an integrated platform for computing-in-memory (CIM) and neuromorphic computing applications. This combination is designed to unlock new multibillion-dollar markets by offering a complete hardware-software solution.
The acquisition is to be funded through a $5 million capital raising, comprising a $3 million pro rata rights issue and a $2 million placement to professional investors, priced at $0.01 per share. The transaction is targeted for completion in October 2026, with Jenesys’s shareholder Jaspal Sarai joining 4DS’s board as Managing Director and CEO upon closing.
Jenesys’s Edge-AI Software Enhances 4DS’s ReRAM Platform
Jenesys, incorporated in late 2025, brings a software suite focused on distributed autonomy, enabling fleets of mixed unmanned vehicles to coordinate in contested and communications-challenged environments without reliance on central command nodes. Its core product, the Distributed Autonomy Stack, is tailored for denied, disrupted, intermittent, and limited bandwidth (DDIL) conditions, spanning air, land, sea, and space domains.
Integrating this software with 4DS’s validated 60nm PCMO ReRAM technology, which offers high endurance and low energy consumption, positions the combined entity to address the demands of real-time, low-power autonomous workloads. The hardware-software synergy is critical for neuromorphic and CIM applications, where device performance hinges on the interplay between memory physics and machine learning workloads.
Capital Raising to Fuel Development and Commercialisation
The $5 million capital raising proceeds will be allocated across several fronts: approximately 27.6% to 4DS’s ReRAM development and hardware-software integration, 30.4% to enhancing the Jenesys platform and expanding its engineering team, and 25% towards business development efforts including securing partnerships and licensing deals. The remainder will cover transaction expenses and working capital.
4DS has engaged JP Equity Holdings as lead manager for the capital raise, with fees structured on cash percentages of funds raised. Participants in the placement will have first rights to any shortfall in the rights issue, ensuring efficient capital deployment.
Transaction Terms and Performance Incentives
Jenesys shareholders will receive $150,000 upfront as a non-refundable deposit, plus $5 million worth of 4DS shares at a deemed price of $0.01 per share. Additionally, six performance rights are tied to milestones including a live demonstration of Jenesys’s technology within 12 months and revenue targets of $2 million and $5 million within 24 and 36 months respectively from completion. These milestones, if met, will convert into additional shares, aligning incentives for commercial success.
The shares issued as consideration will be subject to voluntary escrow periods of six and twelve months, reflecting a commitment to long-term integration and value creation.
Broader Strategic Positioning and Market Validation
4DS’s Executive Chairman David McAuliffe emphasised the acquisition as a strategic step to restore shareholder value and confidence by broadening the company’s technology and market scope. The integration mirrors industry trends where semiconductor companies bundle hardware with software frameworks to reduce adoption risks and accelerate market penetration, seen in players like Qualcomm and NVIDIA.
Recent engagements in India, including discussions with the India Semiconductor Mission and major research institutions, have validated the commercial thesis for 4DS’s 60nm platform, aligning with India’s AUD$25 billion semiconductor investment push. The company is also pursuing renewal of its Joint Development Agreement with HGST, aiming to bolster fabrication and commercial partnerships.
Post-completion, 4DS plans to focus on retuning its ReRAM platform for neuromorphic and CIM applications, integrating Jenesys’s software, fabricating proof-of-concept devices, and securing commercial partnerships and licensing arrangements.
Reinstatement to Trading and Next Steps
Following the announcement, ASX lifted the suspension on 4DS shares, reinstating them to quotation without requiring the company to re-comply with Chapters 1 and 2 of the Listing Rules. The company’s shareholder meeting to approve the acquisition and capital raising is scheduled for 2 October 2026, with settlement and completion expected shortly thereafter.
This transaction marks a pivotal moment for 4DS as it seeks to pivot from prior development discontinuations and align its technology with emerging AI-driven markets. The success of this integration and capital raise will be critical in determining whether 4DS can convert its technical progress into commercial traction.
Bottom Line?
4DS’s acquisition of Jenesys and $5 million capital raise set the stage for a hardware-software platform targeting emerging AI and neuromorphic markets, but execution risks remain on integration and commercial milestones.
Questions in the middle?
- Will the integration of Jenesys’s Edge-AI software with 4DS’s ReRAM hardware accelerate commercial adoption in CIM and neuromorphic computing?
- How effectively can 4DS leverage its new leadership under Jaspal Sarai to navigate the competitive semiconductor and AI software landscape?
- What are the key risks that could delay or derail the achievement of the performance milestones tied to the acquisition?